Global Pantoprazole Sodium Market Size To Worth USD 3.57 Billion by 2033 | CAGR of 6.07%
Category: HealthcareGlobal Pantoprazole Sodium Market Size To Worth USD 3.57 Billion by 2033
According to a research report published by Spherical Insights & Consulting, the Global Pantoprazole Sodium Market Size is expected to grow from USD 1.98 billion in 2023 to USD 3.57 billion by 2033, at a CAGR of 6.07% during the forecast period 2023-2033.
Get more details on this report -
Browse key industry insights spread across 255 pages with 110 Market data tables and figures & charts from the report on the "Global Pantoprazole Sodium Market Size, Share, and COVID-19 Impact Analysis, By Dosage Form (Oral Suspension, Tablets, and Injection), By Dose Strength (20 mg, 40 mg, and Others), By Application (Zollinger-Ellison Syndrome, Gastroesophageal Reflux Disease (GERD), and Others), By End-User (Clinics, Retail Pharmacies, Hospitals, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033." Get Detailed Report Description Here: https://www.sphericalinsights.com/reports/pantoprazole-sodium-market
The pantoprazole sodium market is a pharmaceutical sector that focuses on the development, production, formulation, and commercialization of pantoprazole sodium, a first-generation proton pump inhibitor used to treat acid reflux and gastroesophageal reflux disease (GERD). Pantoprazole sodium improves the solubility and effectiveness of medications and has been approved by the FDA for treating esophagitis and other illnesses. It has off-label applications, such as eliminating Helicobacter pylori bacteria, preventing NSAID-induced ulcers, and stopping rebleeding from peptic ulcers. Pantoprazole, a racemic combination of S (+) and R (+) pantoprazole, covalently binds to the sulfhydryl groups of cysteines on the (H+, K+)-ATPase enzyme at the secretory surface of gastric parietal cells to decrease stomach acid. It is safe for both adult and pediatric use and has a long-lasting anti-secretory effect. The primary distribution of pantoprazole is in the parietal cells of the stomach.
The increasing prevalence of GERD in North America, characterized by symptoms and complications from stomach contents refluxing into the oesophagus, is a major factor in the pantoprazole sodium market. The increasing research and development activities and drug discovery of pantoprazole contribute to its market growth. However, side effects and robust regulatory approvals may impede market growth.
The tablets segment held the largest share in 2023 and is predicted to grow at a significant CAGR during the predicted period.
Based on the dosage form, the global pantoprazole sodium market is categorized into oral suspension, tablets, and injection. Among these, the tablets segment held the largest share in 2023 and is predicted to grow at a significant CAGR during the predicted period. This is attributed to its ease of administration, enhanced stability, longer shelf life, cost-effectiveness, patient compliance, and its high stability and effectiveness in tablet dosage form.
The 40mg segment accounted for the highest market share of 52.11% in 2023 and is expected to grow at a significant CAGR throughout the projected timeframe.
Based on the dose strength, the global pantoprazole sodium market is categorized as 20mg, 40mg, and others. Among these, the 40mg segment accounted for the highest market share of 52.11% in 2023 and is expected to grow at a significant CAGR throughout the projected timeframe. This is driven by its effectiveness against acid reflux, heartburn, Zollinger-Ellison syndrome, gastroesophageal reflux disease, rapid action, and lower stomach acid level reduction.
The gastrointestinal reflux disease (GERD) segment accounted for the highest market share in 2023 and is expected to grow at a significant CAGR throughout the projected timeframe.
Based on the application, the global pantoprazole sodium market is categorized as Zollinger-Ellison syndrome, gastroesophageal reflux disease (GERD), and others. Among these, the gastrointestinal reflux disease (GERD) segment accounted for the highest market share in 2023 and is expected to grow at a significant CAGR throughout the projected timeframe. This is ascribed to global gastroesophageal disease prevalence, sedentary lifestyle, unhealthy food, smoking, obesity, pantoprazole sodium, acid reduction in the stomach, and ideal tolerability.
The hospitals segment held the greatest share in 2023 and is expected to grow at a significant CAGR throughout the projected timeframe.
Based on the end-user, the global pantoprazole sodium market is categorized as clinics, retail pharmacies, hospitals, and others. Among these, the hospitals segment held the greatest share in 2023 and is expected to grow at a significant CAGR throughout the projected timeframe. The growth of the segment is attributed to an increase in inpatient and outpatient services, the availability of pantoprazole sodium in various dosage forms, and an increase in cases of reflux and gastrointestinal oesophageal disease.
North America is expected to hold the greatest share of the global pantoprazole sodium market over the forecast period.
Get more details on this report -
North America is expected to hold the greatest share of the global pantoprazole sodium market over the forecast period. The North American pantoprazole sodium market is driven by factors such as the high prevalence of GERD, improved medication formulations, rising healthcare costs, the aging population, and the availability of affordable generic substitutes. Advancements in fast-dissolving and delayed-release formulations have increased patient compliance and treatment effectiveness. Rising healthcare costs in the US and Canada encourage the use of innovative pharmaceutical remedies, and gastrointestinal problems are more common in the aging population.
Asia Pacific is predicted to grow at the fastest throughout the estimated period. The Asia Pacific Pantoprazole Sodium Market is expanding due to factors such as an aging population, rising gastrointestinal disorders, healthcare access expansion, generic medication preference, and hospital utilization. Urbanization and lifestyle changes, such as unhealthy eating patterns and stress, contribute to this growth. Pharmaceutical research innovations, such as delayed-release tablets, expand therapeutic options. Increased public awareness of digestive health issues and accessible remedies has led to more prescription drug use and medical advice, resulting in a larger pantoprazole sodium market in the region.
Major key players in the global pantoprazole sodium market are Aurobindo Pharma Limited, Teva Pharmaceutical Industries Ltd., Lupin Limited, Alkem Laboratories Ltd., Mylan N.V., AstraZeneca plc., Dr. Reddy‘s Laboratories Ltd., Hetero Labs Limited, Torrent Pharmaceuticals Ltd., Emcure Pharmaceuticals Limited, Sun Pharmaceutical Industries Ltd., Pfizer Inc., and others.
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting and Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Recent Development
- In April 2025, Alembic Pharmaceuticals Limited received approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Pantoprazole Sodium for Injection, 50 mg/vial (Single-Dose Vial). It is therapeutically equivalent to the reference drug product, Protonix I.V. for injection, 40mg/vial of Wyeth Pharmaceuticals LLC.
Market Segment
This study forecasts revenue at global, regional, and country levels from 2023 to 2033. Spherical Insights has segmented the global pantoprazole sodium market based on the below-mentioned segments:
Global Pantoprazole Sodium Market, By Dosage Form
- Oral Suspension
- Tablets
- Injection
Global Pantoprazole Sodium Market, By Dose Strength
- 20mg
- 40mg
- Others
Global Pantoprazole Sodium Market, By Application
- Zollinger-Ellison Syndrome
- Gastroesophageal Reflux Disease (GERD)
- Others
Global Pantoprazole Sodium Market, By End-User
- Clinics
- Retail Pharmacies
- Hospitals
- Others
Global Pantoprazole Sodium Market, By Region
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of the Middle East & Africa
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?